{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:45:19Z","timestamp":1770331519167,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970717"],"award-info":[{"award-number":["81970717"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35461-1","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T17:05:29Z","timestamp":1768064729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Superior prognostic performance of modified N staging incorporating N1c in papillary thyroid carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Hui","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8904-897X","authenticated-orcid":false,"given":"Mingyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0203-5173","authenticated-orcid":false,"given":"Fada","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"35461_CR1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim, H., Devesa, S. S., Sosa, J. A., Check, D. & Kitahara, C. M. Trends in thyroid cancer incidence and mortality in the united States, 1974\u20132013. JAMA 317, 1338\u20131348 (2017).","journal-title":"JAMA"},{"key":"35461_CR2","doi-asserted-by":"crossref","unstructured":"Haugen, B. R. et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1\u2013133 (2016).","DOI":"10.1089\/thy.2015.0020"},{"key":"35461_CR3","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.3390\/curroncol29070350","volume":"29","author":"V Landry","year":"2022","unstructured":"Landry, V., Siciliani, E., Henry, M. & Payne, R. J. Health-Related quality of life following total thyroidectomy and lobectomy for differentiated thyroid carcinoma: A systematic review. Curr. Oncol. 29, 4386\u20134422 (2022).","journal-title":"Curr. Oncol."},{"key":"35461_CR4","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1089\/thy.2022.0109","volume":"32","author":"A Papachristos","year":"2022","unstructured":"Papachristos, A. et al. Outcomes of papillary thyroid microcarcinoma presenting with palpable lateral lymphadenopathy. Thyroid: Off J. Am. Thyroid Assoc. 32, 1086\u20131093 (2022).","journal-title":"Thyroid: Off J. Am. Thyroid Assoc."},{"key":"35461_CR5","doi-asserted-by":"publisher","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual (Springer New York, 2010). https:\/\/doi.org\/10.1007\/978-0-387-88441-7","DOI":"10.1007\/978-0-387-88441-7"},{"key":"35461_CR6","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J. Clin. 67, 93\u201399 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"35461_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1507\/endocrj.EJ15-0677","volume":"63","author":"S Moritani","year":"2016","unstructured":"Moritani, S. Impact of superior mediastinal metastasis on the prognosis of papillary thyroid carcinoma. Endocr. J. 63, 349\u2013357 (2016).","journal-title":"Endocr. J."},{"key":"35461_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10147-019-01522-x","volume":"25","author":"J Zhi","year":"2020","unstructured":"Zhi, J. et al. Assessment of the prognostic value and N1b changes of the eighth TNM\/AJCC staging system for differentiated thyroid carcinoma. Int. J. Clin. Oncol. 25, 59\u201366 (2020).","journal-title":"Int. J. Clin. Oncol."},{"key":"35461_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/1381612823666171009150320","volume":"24","author":"Y Wu","year":"2018","unstructured":"Wu, Y., Li, J., Wu, X. & Dai, L. Level V metastasis, a novel predicative factor for recurrence in N1b papillary thyroid carcinoma. Curr. Pharm. Des. 24, 559\u2013563 (2018).","journal-title":"Curr. Pharm. Des."},{"key":"35461_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5005\/jp-journals-10002-1288","volume":"12","author":"A Mishra","year":"2020","unstructured":"Mishra, A. et al. Bilateral level I lymphadenopathy in differentiated thyroid carcinoma: A case report and review of literature. World J. Endocr. Surg. 12, 41\u201344 (2020).","journal-title":"World J. Endocr. Surg."},{"key":"35461_CR11","doi-asserted-by":"crossref","unstructured":"Tuttle, R. M., Haugen, B. & Perrier, N. D. Updated american joint committee on cancer\/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why? Thyroid 27, 751\u2013756 (2017).","DOI":"10.1089\/thy.2017.0102"},{"key":"35461_CR12","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1245\/s10434-021-11085-9","volume":"29","author":"K Song","year":"2022","unstructured":"Song, K. et al. Patterns of occult metastasis to level Va and Vb in clinically lateral node-positive papillary thyroid carcinoma. Ann. Surg. Oncol. 29, 2550\u20132556 (2022).","journal-title":"Ann. Surg. Oncol."},{"key":"35461_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12022-019-09599-w","volume":"31","author":"JW Feng","year":"2020","unstructured":"Feng, J. W. et al. Predictive factors for lateral lymph node metastasis and skip metastasis in papillary thyroid carcinoma. Endocr. Pathol. 31, 67\u201376 (2020).","journal-title":"Endocr. Pathol."},{"key":"35461_CR14","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.2147\/CMAR.S200628","volume":"11","author":"Y Qiu","year":"2019","unstructured":"Qiu, Y. et al. Prevalence, risk factors and location of skip metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Cancer Manag.  Res. 11, 8721\u20138730 (2019).","journal-title":"Cancer Manag Res."},{"key":"35461_CR15","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1089\/thy.2009.0159","volume":"19","author":"SE Carty","year":"2009","unstructured":"Carty, S. E. et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer: the American thyroid association surgery working group with participation from the American association of endocrine Surgeons, American academy of Otolaryngology\u2014Head and neck surgery, and American head and neck society. Thyroid 19, 1153\u20131158 (2009).","journal-title":"Thyroid"},{"key":"35461_CR16","doi-asserted-by":"publisher","first-page":"8425","DOI":"10.7314\/APJCP.2015.16.18.8425","volume":"16","author":"IS Fayek","year":"2016","unstructured":"Fayek, I. S., Kamel, A. A. & Sidhom, N. F. Safety and prognostic impact of prophylactic level VII lymph node dissection for papillary thyroid carcinoma. Asian Pac. J. Cancer P. 16, 8425\u20138430 (2016).","journal-title":"Asian Pac. J. Cancer P"},{"key":"35461_CR17","first-page":"438","volume":"55","author":"N Aygun","year":"2021","unstructured":"Aygun, N., Kostek, M., Isgor, A. & Uludag, M. Role and extent of neck dissection for neck lymph node metastases in differentiated thyroid cancers. Sisli Etfal Hastan Tip Bul. 55, 438\u2013449 (2021).","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"35461_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12893-020-0675-5","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen, J., Zhang, D., Fang, L., He, G. & Gao, L. Identifying risk factors for metastasis to the level VII lymph node in papillary thyroid carcinoma patients. BMC Surg. 20, 13 (2020).","journal-title":"BMC Surg."},{"key":"35461_CR19","doi-asserted-by":"crossref","unstructured":"Li, G. et al. Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features. CMAR Volume 12, 3371\u20133378 (2020).","DOI":"10.2147\/CMAR.S247914"},{"key":"35461_CR20","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/cam4.792","volume":"5","author":"J Yang","year":"2016","unstructured":"Yang, J. et al. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases. Cancer Med. 5, 2161\u20132168 (2016).","journal-title":"Cancer Med."},{"key":"35461_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/thy.2016.0364","volume":"27","author":"SK Kim","year":"2017","unstructured":"Kim, S. K. et al. Should level V be routinely dissected in N1b papillary thyroid carcinoma? Thyroid 27, 253\u2013260 (2017).","journal-title":"Thyroid"},{"key":"35461_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s13193-020-01167-7","volume":"14","author":"AJ Battoo","year":"2023","unstructured":"Battoo, A. J. et al. Extended level IV neck dissection for limited prophylactic clearance of level V in Node-Positive papillary thyroid carcinoma: a homogenous study population. Indian J. Surg. Oncol. 14, 345\u2013353 (2023).","journal-title":"Indian J. Surg. Oncol."},{"key":"35461_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/00016489.2018.1455008","volume":"138","author":"K Honda","year":"2018","unstructured":"Honda, K. et al. Sensory preservation in neck dissection: outcomes of a sub-sternocleidomastoid approach. Acta Otolaryngol. 138, 763\u2013767 (2018).","journal-title":"Acta Otolaryngol."},{"key":"35461_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/MOO.0000000000000523","volume":"27","author":"SP Murthy","year":"2019","unstructured":"Murthy, S. P., Paderno, A. & Balasubramanian, D. Management of the marginal mandibular nerve during and after neck dissection. Curr. Opin. Otolaryngol. Head Neck Surg. 27, 104\u2013109 (2019).","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"35461_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fendo.2020.00265","volume":"11","author":"J Mao","year":"2020","unstructured":"Mao, J. et al. Risk factors for lymph node metastasis in papillary thyroid carcinoma: A systematic review and Meta-Analysis. Front. Endocrinol. 11, 265 (2020).","journal-title":"Front. Endocrinol."},{"key":"35461_CR26","doi-asserted-by":"publisher","first-page":"e0148420","DOI":"10.1371\/journal.pone.0148420","volume":"11","author":"JH Woo","year":"2016","unstructured":"Woo, J. H., Park, K. N., Lee, J. Y. & Lee, S. W. Predictive factors of superior mediastinal nodal metastasis from papillary thyroid Carcinoma\u2014A prospective observational study. PLoS ONE. 11, e0148420 (2016).","journal-title":"PLoS ONE"},{"key":"35461_CR27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1089\/thy.2016.0068","volume":"26","author":"BW Kim","year":"2016","unstructured":"Kim, B. W., Yousman, W., Wong, W. X., Cheng, C. & McAninch, E. A. Less is more: comparing the 2015 and 2009 American thyroid association guidelines for thyroid nodules and cancer. Thyroid 26, 759\u2013764 (2016).","journal-title":"Thyroid"},{"key":"35461_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-024-01851-1","author":"ZX Cao","year":"2024","unstructured":"Cao, Z. X., Huang, J. S. & Wang, M. M. Application and subgroup analysis of competing risks model based on different lymph node staging systems in differentiated thyroid cancer. Updates Surg. https:\/\/doi.org\/10.1007\/s13304-024-01851-1 (2024).","journal-title":"Updates Surg."},{"key":"35461_CR29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/cen.14729","volume":"97","author":"J Tang","year":"2022","unstructured":"Tang, J. et al. A novel prognostic model based on log odds of positive lymph nodes to predict outcomes of patients with anaplastic thyroid carcinoma after surgery. Clin. Endocrinol. 97, 822\u2013832 (2022).","journal-title":"Clin. Endocrinol."},{"key":"35461_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1210\/jc.2014-1199","volume":"100","author":"S Bardet","year":"2015","unstructured":"Bardet, S. et al. Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer. J. Clin. Endocrinol. Metabol.. 100, 132\u2013140 (2015).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"35461_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/thy.2019.0420","volume":"30","author":"Y Yoshida","year":"2020","unstructured":"Yoshida, Y., Horiuchi, K. & Okamoto, T. Patients\u2019 view on the management of papillary thyroid microcarcinoma: active surveillance or surgery. Thyroid 30, 681\u2013687 (2020).","journal-title":"Thyroid"},{"key":"35461_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.7326\/M16-2472","volume":"167","author":"SY Park","year":"2017","unstructured":"Park, S. Y. et al. Association of coffee consumption with total and Cause-Specific mortality among nonwhite populations. Ann. Intern. Med. 167, 228 (2017).","journal-title":"Ann. Intern. Med."},{"key":"35461_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/thy.2023.0449","volume":"34","author":"TVT Tran","year":"2024","unstructured":"Tran, T. V. T. et al. All-Cause and Cause-Specific mortality among Low-Risk differentiated thyroid cancer survivors in the united States. Thyroid\u00ae 34, 215\u2013224 (2024).","journal-title":"Thyroid\u00ae"},{"key":"35461_CR34","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jclinepi.2014.03.006","volume":"67","author":"M Coory","year":"2014","unstructured":"Coory, M., Lamb, K. E. & Sorich, M. Risk-difference curves can be used to communicate time-dependent effects of adjuvant therapies for early stage cancer. J. Clin. Epidemiol. 67, 966\u2013972 (2014).","journal-title":"J. Clin. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35461-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:20:00Z","timestamp":1770286800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35461-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35461"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35461-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4998"}}